Literature DB >> 17513107

Design, synthesis, and binding studies of bidentate Zn-chelating peptidic inhibitors of glyoxalase-I.

Swati S More1, Robert Vince.   

Abstract

The known affinity of ethyl acetoacetate (ACC) toward divalent zinc prompted us to attempt its employment as a chelating moiety in the design of glyoxalase-I inhibitors. A practical synthetic route was developed to incorporate this pharmacophore into the side chain of glutamic acid, with flexibility to allow incorporation of additional functionality at the end-stage of the synthesis. Herein, the details of this synthetic approach as well as the evaluation of the resultant beta-keto ester compounds are reported.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17513107     DOI: 10.1016/j.bmcl.2006.12.056

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Targeting Metalloenzymes for Therapeutic Intervention.

Authors:  Allie Y Chen; Rebecca N Adamek; Benjamin L Dick; Cy V Credille; Christine N Morrison; Seth M Cohen
Journal:  Chem Rev       Date:  2018-09-07       Impact factor: 60.622

2.  Multi-Armed 1,2,3-Selenadiazole and 1,2,3-Thiadiazole Benzene Derivatives as Novel Glyoxalase-I Inhibitors.

Authors:  Qosay A Al-Balas; Mousa L Al-Smadi; Mohammad A Hassan; Ghazi A Al Jabal; Ammar M Almaaytah; Karem H Alzoubi
Journal:  Molecules       Date:  2019-09-04       Impact factor: 4.411

3.  Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors.

Authors:  Suaad Abdallah Audat; Qosay Ali Al-Balas; Buthina Abdallah Al-Oudat; Mo'ad Jamil Athamneh; Amanda Bryant-Friedrich
Journal:  Drug Des Devel Ther       Date:  2022-03-28       Impact factor: 4.162

4.  Novel glyoxalase-I inhibitors possessing a "zinc-binding feature" as potential anticancer agents.

Authors:  Qosay A Al-Balas; Mohammad A Hassan; Nizar A Al-Shar'i; Nizar M Mhaidat; Ammar M Almaaytah; Fatima M Al-Mahasneh; Israa H Isawi
Journal:  Drug Des Devel Ther       Date:  2016-08-17       Impact factor: 4.162

5.  Generation of the first structure-based pharmacophore model containing a selective "zinc binding group" feature to identify potential glyoxalase-1 inhibitors.

Authors:  Qosay Al-Balas; Mohammad Hassan; Buthina Al-Oudat; Hassan Alzoubi; Nizar Mhaidat; Ammar Almaaytah
Journal:  Molecules       Date:  2012-11-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.